MedTrace Logo

Er,Cr:YSGG Laser Application in Peri-implantitis

NCT06031467 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2023-09-14

No results posted yet for this study

Summary

In the present study, investigators, aimed to evaluate the effect of erbium, chromium:yttrium-scandium-gallium-garnet (Er,Cr:YSGG) laser application combined with mechanical debridement (MD) on clinical parameters and biochemical parameters such as receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin (OPG) in patients with peri-implant diseases.

Conditions

  • Peri-Implantitis

Interventions

DEVICE

Er, Cr: YSGG laser-assisted non-surgical mechanical therapy

The laser group received mechanical therapy followed by Er;Cr;YSGG laser. Laser application was performed using the bottom-up technique. Therefore, the tip was retracted about 1 mm after it was placed on the bottom of the pocket and slowly moved in the coronal direction to the parallel to the implant surface.

DEVICE

Non-surgical mechanical therapy

Traditional non surgical mechanical therapy Mechanical instrumentation in all groups was made with titanium curettes.The curette was gently inserted into the peri-implant pocket and the mechanical therapy was completed with threads felt.

Sponsors & Collaborators

  • Yuzuncu Yıl University

    lead OTHER

Principal Investigators

  • Nazli Zeynep Alpaslan, PhD · Yuzuncu Yıl University

  • Dicle Altindal, PhD · Yuzuncu Yıl University

  • Damla Akbal, PhD · Private Dental Clinic

  • Ahmet Cemil Talmac, PhD · Yuzuncu Yıl University

  • Serap Keskin Tunc, PhD · Saglik Bilimleri Universitesi

  • Abdullah Seckin Ertugrul, PhD · Izmir Katip Celebi University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
28 Years
Max Age
63 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-03
Primary Completion
2022-04-08
Completion
2022-04-08

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06031467 on ClinicalTrials.gov